Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - DYN
1. DJS Law Group is investigating Dyne Therapeutics for possible securities law violations. 2. Misleading statements by Dyne may have caused a significant share price drop. 3. On June 17, shares fell over 19.4% following Dyne's FDA-related announcement. 4. The investigation aims to determine if they failed to disclose critical information.